Theralase Technologies Inc. V.TLT

Alternate Symbol(s): TLTFF

Healthcare Medical Devices

Theralase Technologies Inc. is a Canada-based clinical-stage pharmaceutical company. The Company is engaged in the research and development of light activated compounds and their associated drug formulations. The Company operates through two divisions: Anti-Cancer Therapy (ACT) and Cool Laser Therapy (CLT). The Anti-Cancer Therapy division develops patented, and patent pending drugs, called Photo Dynamic Compounds (PDCs) and activates them with patent pending laser technology to destroy specifically targeted cancers, bacteria and viruses. The CLT division is responsible for the Company’s medical laser business. The Cool Laser Therapy division designs, develops, manufactures and markets super-pulsed laser technology indicated for the healing of chronic knee pain. The technology has been used off-label for healing numerous nerve, muscle and joint conditions. The Company develops products both internally and using the assistance of specialist external resources.

TSXV:TLT - Post by User

Theralase Technologies Inc. > imagine the questions a big investor would ask..

<< Previous

Bullboard Posts

Next >>

Comment by charlierockon Jul 17, 2024 6:31am

89 Views

Post# 36136136

RE:RE:RE:RE:RE:RE:RE:RE:imagine the questions a big investor would ask..

Paradise818 wrote:
As I been saying. The FDA, NIH are crooked to the bone. When you have former members of the FDA go to work for big Pharma after their term are done, you have a major conflict of interest. The FDA really doesn't have the best interest of patients otherwise we would have been fast tracked a while ago based on the results. Hopefully, this all ends soon.

TLT received fast track designation from the FDA back on November 23rd 2020. Go back and read the news release.

<< Previous

Bullboard Posts

Next >>

Sony’s Alpha 1 II: A new professional photography standard?